Affiliation
Graduate School of Medicine Endowed Course Community Healthcare Department in Oodate and North-Akita
MIZUNUMA MAKITO
Degree
-
博士(医学)
-
学士(医学)
Education
-
Hirosaki University 医学部 医学科 Doctor's Course Completed Graduated
2004.04 ～ 2010.03
Country： Japan
Campus Career
-
Hirosaki University Graduate School of Medicine Endowed Course Community Healthcare Department in Oodate and North-Akita Assistant Professor
2025.04 ～ Now
-
Hirosaki University Graduate School of Medicine Medical Science Course Obstetics and Gynecology Assistant Professor
2022.04 ～ 202503
-
Hirosaki University School of Medicine Medicine Graduate student(doctorate program)
2013.10 ～ 201603
Research History
-
National Institutes of Health National Cancer Institute Researcher
2022.04 ～ 2024.03
Research Interests
-
TRPM4
-
SLFN11
-
Acetalax
Research Areas
-
Life Science / Obstetrics and gynecology
Professional Memberships
-
Japan Society of Clinical Oncology
-
日本臨床細胞診学会
-
日本産婦人科学会
-
日本内視鏡外科学会
-
日本産科婦人科内視鏡学会
-
日本婦人科腫瘍学会
Papers
-
Clinical and prognostic insights into Trousseau’s syndrome in gynecologic malignancies: a multicenter study
Hemian Zhang, Makito Mizunuma
2026.1
-
Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
Mizunuma M
Cancer Research Communications 5 ( 2 ) 375 - 388 2025.2
-
治療にリンパ管造影と塞栓術を要した難治性リンパ嚢胞の２例
立崎善郎、水沼槙人
青森県臨床産婦人科医会誌 40 ( 1 ) 7 2025
-
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4
Mizunuma M
Cancer Res Commun 2024.8
-
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs
Mizunuma M
Molecular Cancer Therapeutics 23 ( 7 ) 911 - 923 2024.7
-
Adult-onset Still’s Disease during Pregnancy Treated with Tocilizumab
Mizunuma M
Internal Medicine 61 3137 - 3140 2022.10
-
Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences
Mizunuma M
Oncology Letters 13 ( 6 ) 4933 - 4938 2017.6
-
FOXP1 forkhead transcription factor is associated with the pathogenesis of endometrial cancer
Mizunuma M
Heliyon 2016.5
-
A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer
Mizunuma M
Cancer Research Communications 17 ( 2 ) 775 - 779 2016
-
The pretreatment neutrophil‑to‑lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer
Mizunuma M
Int J Clin Oncol 20 989 - 996 2015.2
-
The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer
Mizunuma M
Journal of Ovarian Research 2014.11